CSL112 (apolipoprotein A-I (human)) Drug Research Report 2024: A Novel Formulation of Plasma-derived apoA-I - Market Size, Forecasts, and Emerging Insights 2019-2032
15 avr. 2024 10h09 HE
|
Research and Markets
Dublin, April 15, 2024 (GLOBE NEWSWIRE) -- The "CSL112 Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...